Levy on pharmaceutical companies' turnover raised to 1.6% for 2012 to 2014
The 2012 Social Security Financing Act set at 1.6% the rate of the levy on turnover owed by companies marketing pharmaceutical products for turnover in 2012, 2013 and 2014 (Article L. 245-6 of the Social Security Code). The previous rate was 1%, according to the health minister.
Measure originators
A positive amount is revenue or savings for public finances; a negative amount is a cost or lost revenue.
Measure impact
Affects companies marketing reimbursable medicines. The health minister announced an extra yield of €150 million to fund continuing medical education.
Official references
Sources
Procedure timeline
Follow the progress of this fiscal measure through the different stages of the parliamentary procedure.
Administrative implementation
Entrée en vigueur de la mesure et mise en œuvre par l'administration
President of the Republic signature
Publication au Journal officiel
Possible referral to Constitutional Council
Décision de conformité / censure partielle
National Assembly has the final say
Si échec CMP
Debate and vote
Debate and vote
Débat et vote en séance publique à l'Assemblée nationale, ou engagement de la responsabilité du Gouvernement (article 49.3)